DMIN BSc - ZEN Graphene Chief Officer

ZTEK Stock  USD 1.15  0.01  0.88%   

Executive

DMIN BSc is Chief Officer of ZEN Graphene Solutions
Address 24 Corporate Court, Guelph, ON, Canada, N1G 5G5
Phone844-730-9822
Webhttps://www.zentek.com

ZEN Graphene Management Efficiency

The company has return on total asset (ROA) of (0.2709) % which means that it has lost $0.2709 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4777) %, meaning that it created substantial loss on money invested by shareholders. ZEN Graphene's management efficiency ratios could be used to measure how well ZEN Graphene manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -0.49 this year. Return On Capital Employed is expected to rise to -0.5 this year. Liabilities And Stockholders Equity is expected to rise to about 24 M this year, although the value of Total Current Liabilities will most likely fall to about 1 M.
ZEN Graphene Solutions currently holds 1.24 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. ZEN Graphene Solutions has a current ratio of 7.73, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ZEN Graphene's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

John GriffinHologic
63
Erik AndersonHologic
42
Peter DunneHologic
68
Jan MDHaemonetics
N/A
John JDHologic
63
Clay SchwabePrecision Optics,
N/A
Benjamin CohnHologic
N/A
Scott ChristensenHologic
N/A
Rajeev VarmaHaemonetics
N/A
Brianne McGuireNephros
N/A
Diana SPHRHologic
N/A
James JDMilestone Scientific
N/A
Judy MazziniNephros
N/A
Rob CannonRepro Med Systems
N/A
MS MBANephros
50
Christopher PazdanRepro Med Systems
N/A
Jeffrey DiRubioPrecision Optics,
N/A
Andy MolnarMilestone Scientific
62
Christian VoigtlanderICU Medical
56
Kerri DiPietroHaemonetics
N/A
Kenneth MillerRepro Med Systems
55
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada. Zentek is traded on NASDAQ Exchange in the United States. ZEN Graphene Solutions (ZTEK) is traded on NASDAQ Exchange in USA. It is located in 24 Corporate Court, Guelph, ON, Canada, N1G 5G5 and employs 24 people. ZEN Graphene is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

ZEN Graphene Solutions Leadership Team

Elected by the shareholders, the ZEN Graphene's board of directors comprises two types of representatives: ZEN Graphene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ZEN. The board's role is to monitor ZEN Graphene's management team and ensure that shareholders' interests are well served. ZEN Graphene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ZEN Graphene's outside directors are responsible for providing unbiased perspectives on the board's policies.
Francis BSc, COO Director
Gregory CFA, CEO Director
Ryan Shacklock, Senior Development
CFA BA, COO Director
DMIN BSc, Chief Officer

ZEN Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ZEN Graphene a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ZEN Graphene Solutions is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ZEN Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Zen Graphene Solutions Stock. Highlighted below are key reports to facilitate an investment decision about Zen Graphene Solutions Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in ZEN Graphene Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ZEN Graphene. If investors know ZEN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ZEN Graphene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.07)
Quarterly Revenue Growth
(0.40)
Return On Assets
(0.27)
Return On Equity
(0.48)
The market value of ZEN Graphene Solutions is measured differently than its book value, which is the value of ZEN that is recorded on the company's balance sheet. Investors also form their own opinion of ZEN Graphene's value that differs from its market value or its book value, called intrinsic value, which is ZEN Graphene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ZEN Graphene's market value can be influenced by many factors that don't directly affect ZEN Graphene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ZEN Graphene's value and its price as these two are different measures arrived at by different means. Investors typically determine if ZEN Graphene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ZEN Graphene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.